Frovatriptan
- Generic Name
- Frovatriptan
- Brand Names
- Frova
- Drug Type
- Small Molecule
- Chemical Formula
- C14H17N3O
- CAS Number
- 158747-02-5
- Unique Ingredient Identifier
- H82Q2D5WA7
Overview
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.
Background
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.
Indication
For the acute treatment of migraine attacks with or without aura in adults.
Associated Conditions
- Migraine With Aura
- Migraine Without Aura
- Migraine;Menstrual
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath